Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories total assets
Total assets on the balance sheet at the end of each period.
Bio-Rad Laboratories's total assets was $10.25B at Jun 30, 2026. For fiscal 2025 it was $10.58B, up 12.9% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is $17.80B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.58B | +12.9% |
| FY2024 | Dec 31, 2024 | $9.36B | -23.9% |
| FY2023 | Dec 31, 2023 | $12.30B | -8.9% |
| FY2022 | Dec 31, 2022 | $13.50B | -24.1% |
| FY2021 | Dec 31, 2021 | $17.80B | +37.2% |
| FY2020 | Dec 31, 2020 | $12.97B | +62.0% |
| FY2019 | Dec 31, 2019 | $8.01B | +42.7% |
| FY2018 | Dec 31, 2018 | $5.61B | +31.3% |
| FY2017 | Dec 31, 2017 | $4.27B | +11.0% |
| FY2016 | Dec 31, 2016 | $3.85B | +3.8% |
| FY2015 | Dec 31, 2015 | $3.71B | +11.0% |
| FY2014 | Dec 31, 2014 | $3.34B | -1.4% |
| FY2013 | Dec 31, 2013 | $3.39B | -1.6% |
| FY2012 | Dec 31, 2012 | $3.44B | +11.2% |
| FY2011 | Dec 31, 2011 | $3.10B | +1.1% |
| FY2010 | Dec 31, 2010 | $3.06B | +20.8% |
| FY2009 | Dec 31, 2009 | $2.54B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.25B | +0.4% |
| Q1 FY2026 | Mar 31, 2026 | $9.79B | +2.8% |
| Q4 FY2025 | Dec 31, 2025 | $10.58B | +12.9% |
| Q3 FY2025 | Sep 30, 2025 | $9.70B | -8.6% |
| Q2 FY2025 | Jun 30, 2025 | $10.21B | +5.4% |
| Q1 FY2025 | Mar 31, 2025 | $9.53B | -24.4% |
| Q4 FY2024 | Dec 31, 2024 | $9.36B | -23.9% |
| Q3 FY2024 | Sep 30, 2024 | $10.60B | -10.9% |
| Q2 FY2024 | Jun 30, 2024 | $9.69B | -19.1% |
| Q1 FY2024 | Mar 31, 2024 | $12.61B | -7.7% |
| Q4 FY2023 | Dec 31, 2023 | $12.30B | -8.9% |
| Q3 FY2023 | Sep 30, 2023 | $11.90B | -1.3% |
| Q2 FY2023 | Jun 30, 2023 | $11.98B | -5.6% |
| Q1 FY2023 | Mar 31, 2023 | $13.67B | -4.9% |
| Q4 FY2022 | Dec 31, 2022 | $13.50B | -24.1% |
| Q3 FY2022 | Sep 30, 2022 | $12.06B | -39.6% |
| Q2 FY2022 | Jun 30, 2022 | $12.68B | -16.1% |
| Q1 FY2022 | Mar 31, 2022 | $14.37B | +3.2% |
| Q4 FY2021 | Dec 31, 2021 | $17.80B | +37.2% |
| Q3 FY2021 | Sep 30, 2021 | $19.95B | +66.0% |
| Q2 FY2021 | Jun 30, 2021 | $15.12B | +49.7% |
| Q1 FY2021 | Mar 31, 2021 | $13.93B | +60.4% |
| Q4 FY2020 | Dec 31, 2020 | $12.97B | +62.0% |
| Q3 FY2020 | Sep 30, 2020 | $12.02B | +67.5% |
| Q2 FY2020 | Jun 30, 2020 | $10.10B | +32.0% |
| Q1 FY2020 | Mar 31, 2020 | $8.68B | +26.5% |
| Q4 FY2019 | Dec 31, 2019 | $8.01B | +42.7% |
| Q3 FY2019 | Sep 30, 2019 | $7.18B | +6.8% |
| Q2 FY2019 | Jun 30, 2019 | $7.65B | +19.7% |
| Q1 FY2019 | Mar 31, 2019 | $6.86B | +10.4% |
| Q4 FY2018 | Dec 31, 2018 | $5.61B | +31.3% |
| Q3 FY2018 | Sep 30, 2018 | $6.72B | +60.5% |
| Q2 FY2018 | Jun 30, 2018 | $6.39B | +54.1% |
| Q1 FY2018 | Mar 31, 2018 | $6.21B | +57.2% |
| Q4 FY2017 | Dec 31, 2017 | $4.27B | +11.0% |
| Q3 FY2017 | Sep 30, 2017 | $4.19B | +4.1% |
| Q2 FY2017 | Jun 30, 2017 | $4.14B | – |
| Q1 FY2017 | Mar 31, 2017 | $3.95B | – |
| Q4 FY2016 | Dec 31, 2016 | $3.85B | – |
| Q3 FY2016 | Sep 30, 2016 | $4.02B | – |